SCHEMBL24253871

SCHEMBL24253871

CCc1cc(NC(=O)N2CCC(N3CCCCC3)CC2)ccc1Br

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP2C19 P33261 1/20 0.63
MAPT P10636 3/20 0.56
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
KMT2A Q03164 1/20 0.50
THRB P10828 3/20 0.47
TP53 P04637 1/20 0.47
LMNA P02545 1/20 0.47
MBTD1 Q05BQ5 1/20 0.47
ALDH1A1 P00352 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL3 Q96JM7 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SHMT2 P34897 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24253870 0.77 CYP2D6 (0.56) CYP2D6CYP2C19MAPTRAB9ANPC1
SCHEMBL14413284 0.76 CYP3A4 (0.68) CYP3A4CYP2D6CYP2C19MAPTESR1
SCHEMBL13533524 0.73 CYP3A4 (0.59) CYP3A4CYP2D6CYP2C19MAPTESR1
SCHEMBL13452253 0.71 KMT2A (0.65) CYP3A4CYP2D6CYP2C19MAPTESR1
SCHEMBL13612755 0.70 RAB9A (0.72) CYP3A4CYP2D6CYP2C19MAPTRAB9A
SCHEMBL256088 0.70 L3MBTL1 (0.60) MAPTRAB9ANPC1KMT2ATHRB
SCHEMBL13873287 0.70 EPHX2 (0.77) CYP3A4CYP2D6CYP2C19SMN1; SMN2
SCHEMBL13452255 0.70 NPC1 (0.60) CYP3A4CYP2D6CYP2C19MAPTESR1
SCHEMBL4767666 0.69 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C19MAPTESR1
SCHEMBL13452062 0.69 CYP3A4 (0.55) CYP3A4CYP2D6CYP2C19MAPTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022034587-A1 Traf2- AND Nck-INTERACTING KINASE (TNIK) INHIBITORS AND USES THEREOF TNIK THERAPEUTICS LTD (IL) 2022-02-17 WO disclosed